Novel oxidative pathways of sulphapyridine and sulphadiazine by the turtle Pseudemys scripta elegans.
The sulphonamides sulphapyridine and sulphadiazine show novel hydroxy metabolites in the turtle Pseudemys scripta elegans. In the excreta of the turtles the monohydroxy metabolites 4-hydroxy- and 5-hydroxysulphapyridine and the dihydroxy metabolite 4,5-dihydroxysulphapyridine were detected. Of sulphadiazine only dihydroxy metabolites 4,5- and 4,6-dihydroxysulphadiazine were detected. About 70-90% of the dose of sulphapyridine was recovered, while this figure varied between 48 and 69% for sulphadiazine.
Vree
T B
TB
Department of Clinical Pharmacy, Academic Hospital Nijmegen Sint Radboud, The Netherlands.
Vree
J B
JB
Beneken Kolmer
E W
EW
Hekster
Y A
YA
D000818:Animals; D002851:Chromatography, High Pressure Liquid; D005260:Female; D008297:Male; D010084:Oxidation-Reduction; D013411:Sulfadiazine / Q000493:pharmacokinetics*; D013427:Sulfapyridine / Q000493:pharmacokinetics*; D014426:Turtles / Q000378:metabolism*
D013411:Sulfadiazine; D013427:Sulfapyridine